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Dermatoﬁbroma, also known as “ﬁbrous histiocytoma”, is a benign dermal or subcutaneous poorly circumscribed proliferation
of spindle-shaped ﬁbroblasts and macrophages in the dermis. Although it is commonly present as a brownish nodule the legs of
females, it may also arise on the upper extremities, trunk, and rarely on the head. The exact pathogenesis is unclear. However, it is
widely believed that the originating insult to the dermis is a folliculitis, an arthropod bite, or an unspeciﬁed initial inﬂammatory
condition. Giant dermatoﬁbromas of greater than 5cm in diameter are rare, with only 22 cases reported in the literature. We
present a case of a rapidly evolving pedunculated mass in the groin of a male patient. Histological examination conﬁrmed this to
be a giant dermatoﬁbroma. Though this specimen cannot is not conﬁrmed as such, the cellular subtype is sometimes present as
a larger lesion with anecdotal reports of local recurrence and distant metastases. The clinical and radiological features which were
somewhat suspicious of malignancy are considered in the context of the deﬁnitive pathological diagnosis of a benign lesion.
1.Introduction
Dermatoﬁbromaisacommon,usuallybenign,smallpapular
(<5mm) skin lesion often found on the lower limbs [1]. A
number of clinicopathological variants have been described
which include the cellular variant representing less than
5% of the cases, but more commonly encountered in
larger lesions [2]. We report a case of an unusually large
dermatoﬁbroma with an apparently rapid phase of growth
which led to a clinical suspicion of malignancy.
2.CaseReport
A 61-year-old man presented to his general practitioner with
a history of a rapidly evolving groin swelling. He recalled a
pea-sized lesion in his right groin, which had remained static
over the past 40 years. There was no relevant past medical
history and the patient remembered no preceding episode of
trauma or local irritation.
The lesion increased rapidly in size to a 10.5 ×
10 × 6cm ﬁrm, smooth exophytic mass with a shiny reddish
surface. The centre was ulcerated discharging pus (Figure 1).
The patient was referred for a surgical opinion.
Computed tomography of the lesion showed a complex
cystic structure with ﬂuid and septations containing several
foci of calciﬁcation (Figure 2). The lesion was excised under
general anaesthetic.
Histologicalexaminationshowedamacroscopicallywell-
circumscribed, pedunculated, partly ulcerated lesion weigh-
ing 406.6grams. On slicing, a well-circumscribed multilob-
ulated mass with a variegated cut surface including cystic
and haemorrhagic areas was apparent (Figure 3). Four tissue
blocks were ﬁxed for analysis.
All the tissue blocks were ﬁxed in formalin and routinely
processedforparaﬃn-embedding.Histologicalsectionswere
stained with haematoxylin and eosin (H&E). Immunohis-
tochemical studies were carried out using a standard panel
of mesenchymal and melanocytic markers. Microscopically,
the specimen contained a large spindle cell lesion extending
from the dermis into the subcutaneous tissue. A well-deﬁned
Grenz zone was apparent away from the ulceration and
bundlesofinterlacingspindlecellssurroundingsmallgroups
of foamy macrophages were present. A storiform pattern was
noted. At the centre of the lesion there were areas of cystic
degeneration with focal haemorrhage, cholesterol clefting,
and giant cells with focal calciﬁcation (Figure 4).2 Case Reports in Medicine
Figure 1: Anterior view of dermatoﬁbroma (10.5cm ×
10cm × 6cm) in the right inguinal region. Ulcerated area is
covered with tegapore dressing.
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Figure 2: Axial computed-tomography view of dermatoﬁbroma
(arrowed) arising from the skin of the right base of the scrotum
demonstrating a complex cystic structure with ﬂuid and septations.
Figure 3: Excised tissue, sliced longitudinally, showing cystic and
haemorrhagic areas.
Immunohistochemical staining was positive for CD68
and factor XIIIa. The spindle cells stained strongly positive
for factor XIIIa. Focal positivity with CD31 and SMA was
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Figure 4: On low power the lesion is composed of spindled
cells in the dermis with a well deﬁned Grenz zone; H&E stain,
moderatemagniﬁcation ×40.Onhighpower,bundlesofinterlacing
spindle cells in the dermis. H&E stain, magniﬁcation ×100.
Same area of lesion as in (b) stained for Factor XIIIa, showing
diﬀuse staining with scattered strongly positive cells; Factor XIIIa
stain, magniﬁcation ×100. High powered section of specimen
showing cholesterol clefting and scattered giant cells; H&E stain,
magniﬁcation ×100
noted. Staining for CD34, desmin, MNF116, S100 protein,
and AE1/AE3 negative. The morphological and immunohis-
tochemical features were those of a dermatoﬁbroma showing
marked degenerative changes. At three-month follow-up the
patient was well with no evidence of recurrence.Case Reports in Medicine 3
3. Discussion
Themostfrequentclinicalpresentationofdermatoﬁbromais
of a red-brown or yellow-brown papule on the leg measuring
afewmillimetresindiameter-whichismostlyasymptomatic.
Twenty percent of dermatoﬁbromas occur in persons less
than 17 years old. It almost invariably exhibits benign
biologic behaviour. Clinically, it moves freely over the deeper
layers on palpation and if the overlying epidermis is inwardly
compressed,itexhibitsthe“dimplesign”,indicatingtethering
of the overlying epidermis to the underlying lesion. Pruritus
and tenderness are not uncommon [2].
The aetiology of the lesion is controversial and was
thought to represent a reactive process or dermal response
to injury following an insult such as folliculitis, arthropod
bites, or unspeciﬁed inﬂammatory conditions. However,
recent cytogenetic studies demonstrating clonality suggest
that these lesions may in fact be neoplastic [3]. Some prefer
to think of dermatoﬁbroma as a ﬁbrosing dermatitis rather
than a neoplasm [4, 5].
Histological ﬁndings in dermatoﬁbroma typically
include a degree of epidermal hyperplasia of the overlying
epidermis. Sometimes, the basaloid proliferation simulates
a basal cell carcinoma and the pathologist must be cautious
of confusing these distinctly diﬀerent entities. The dermis
displays a poorly circumscribed proliferation of spindle
cells associated with varying numbers of mononuclear cells.
The line of diﬀerentiation of these spindle-shaped cells
remains uncertain. These lesions are therefore classiﬁed
as “ﬁbrohistiocytic tumours” because of their appearance
and the histopathological ﬁndings of a variable mixture
of ﬁbrocytes and macrophages. Foamy macrophages are
commonly seen in varying numbers [1].
Cellular dermatoﬁbroma is a rare subtype representing
less than 5% of all ﬁbrous histiocytomas. This pathological
variant, while still favouring the lower limbs, is more
common in males and most are less than 2cm in diameter.
When very large, the lesions may present clinically as a giant
dermatoﬁbroma. The features widely accepted as deﬁning a
giant dermatoﬁbroma were ﬁrst described by Requena et al
[6] in their 1994 series of eight cases of dermatoﬁbroma:
(a) size >5cm; (b) pedunculated; (c) benign biological
behaviour despite its size; and (d) the same histopathological
characteristics as conventional dermatoﬁbroma. In the same
series, none of the lesions excised recurred at an average of
35 months follow-up, suggesting that surgical management
represents a satisfactory management strategy in giant
dermatoﬁbroma.
The diﬀerential diagnosis of dermatoﬁbroma must
include dermatoﬁbrosarcoma protuberans. Immunohisto-
chemical staining for CD34 is usually negative in benign
lesions (positive in 85% of dermatoﬁbrosarcoma protuber-
ans) and may be the only distinguishing characteristic. How-
ever, it should be noted that cellular dermatoﬁbroma may
focally stain positive for CD34 though this is predominantly
seen at the periphery of the tumour. Staining for factor
XIIIa is positive in dermatoﬁbroma and tends to be negative
in dermatoﬁbrosarcoma protuberans [7, 8]. Staining for
smooth muscle actin is often focally positive in cellular
dermatoﬁbroma. By contrast, this stain is usually negative in
cases of dermatoﬁbrosarcoma protuberans.
We can speculate that an unrecognised inﬂammatory
and/orhaemorrhagicprocessintheperiodprecedingpresen-
tation induced the rapid growth of the lesion in our patient.
The speed of evolution of the lesion and the clinical ﬁndings
did raise a suspicion of malignancy. However, preoperative
computed tomography was more in keeping with a benign
lesion.Becauseoftheclinicalconcernsthislesionwasexcised
with appropriate margins and submitted for pathological
assessment. In light of the pathological diagnosis of a
giant dermatoﬁbroma (an aneurysmal ﬁbrous histiocytoma)
which appears excised no further treatment is indicated.
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